高迁移率族蛋白B1、血管性血友病因子及其他细胞因子在评估脓毒症患者病情严重程度及预后中的意义
该研究纳入滨州医学院附属医院重症医学科2019年1月至6月收治的11例脓毒症和25例脓毒性休克患者,以30例健康体检者为对照,检测血清HMGB1、vWF、TNF-α、IL-10、sTM、VEGFR-2、Ang-2等细胞因子。结果显示脓毒症/脓毒性休克患者上述细胞因子水平显著高于健康对照,死亡组TNF-α、IL-10、HMGB1、vWF、sTM高于生存组而Ang-2低于生存组。HMGB1、vWF、IL-10、sTM预测28天死亡的AUC均高于APACHE II评分。Logistic回归显示APACHE II评分、vWF、sTM、IL-10为28天死亡的独立危险因素。
要点
- 脓毒症/脓毒性休克患者血清TNF-α、IL-10、HMGB1、vWF、sTM、VEGFR-2水平显著高于健康对照。
- 脓毒性休克组TNF-α、IL-10、HMGB1、vWF、sTM高于脓毒症组,而Ang-2水平显著降低。
- 28天死亡组TNF-α、IL-10、HMGB1、vWF、sTM高于生存组,Ang-2低于生存组。
- HMGB1、vWF、IL-10、sTM预测28天死亡的AUC分别为0.946(95%CI 0.870-1.000)、0.902(95%CI 0.790-1.000)、0.877(95%CI 0.745-1.000)、0.868(95%CI 0.734-1.000),均高于APACHE II评分的0.846(95%CI 0.700-0.991)。
- APACHE II评分、vWF、sTM、IL-10为脓毒症/脓毒性休克患者28天死亡的独立危险因素(β值分别为4.731、0.407、-7.058、-0.887,均P<0.05)。
适用人群与场景
- 纳入标准:≥18岁、符合Sepsis-3诊断标准、2019年1月至6月收治于滨州医学院附属医院重症医学科的脓毒症和脓毒性休克患者。
- 对照:同期健康体检者。
诊断标准与关键阈值
- 脓毒症诊断采用Sepsis-3诊断标准。
研究设计与关键结果
- 研究类型为病例对照研究,纳入11例脓毒症、25例脓毒性休克患者及30例健康对照;脓毒症/脓毒性休克患者中28天死亡15例、存活21例。
- 脓毒症组血清TNF-α、IL-10、HMGB1、vWF、sTM、VEGFR-2水平显著高于健康对照组。
- 脓毒性休克组TNF-α、IL-10、HMGB1、vWF、sTM水平高于脓毒症组,而Ang-2水平显著降低。
- 28天死亡组血清TNF-α、IL-10、HMGB1、vWF、sTM水平高于生存组,Ang-2低于生存组。
- Spearman相关分析:HMGB1、TNF-α、sTM、IL-10、vWF与APACHE II评分正相关(r值分别为0.652、0.666、0.445、0.430、0.355,均P<0.05);HMGB1、TNF-α与SOFA评分正相关(r值分别为0.433、0.479,均P<0.05);Ang-2与APACHE II及SOFA评分负相关(r值分别为-0.519、-0.440,均P<0.05)。
- ROC曲线分析:HMGB1、vWF、IL-10、sTM预测28天死亡的AUC(95%CI)分别为0.946(0.870-1.000)、0.902(0.790-1.000)、0.877(0.745-1.000)、0.868(0.734-1.000),均高于APACHE II评分的0.846(0.700-0.991)。
- Logistic回归分析:APACHE II评分、vWF、sTM、IL-10为28天死亡的独立危险因素(β值分别为4.731、0.407、-7.058、-0.887,均P<0.05)。
证据类型、等级与局限
- 证据类型:病例对照研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为HMGB1、vWF、IL-10、sTM等细胞因子均可用于评估脓毒症患者的病情严重程度及预后。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVE: To explore the value of high mobility group box 1 (HMGB1), von Willebrand factor (vWF) and other cytokines in predicting the severity and prognosis of sepsis patients.
METHODS: Patients with sepsis and septic shock who ≥ 18 years old and met the Sepsis-3 diagnostic criteria admitted to the department of critical care medicine of Binzhou Medical University Hospital from January to June 2019 were taken as the research objects. The healthy individuals for regular health examination in the same period were taken as the control. The basic information, acute physiology and chronic health evaluation II (APACHE II) and sequential organ failure assessment (SOFA) scores were recorded. The venous blood was taken within 24 hours after the patients were diagnosed. The levels of HMGB1, vWF, tumour necrosis factor-α (TNF-α), interleukin-10 (IL-10), soluble thrombomodulin (sTM), vascular endothelial growth factor receptor 2 (VEGFR-2), angiopoetin-2 (Ang-2) and other cytokines in serum were determined by enzyme linked immunosorbent assay (ELISA). Differences among patients with sepsis, septic shock, healthy physical examinees, and patients who died in 28-day and those who survived, were compared. Spearman rank correlation method was used to analyze the correlation among each cytokine and APACHE II, SOFA scores. The receiver operating characteristic (ROC) curve was drawn to evaluate the predictive value of cytokines on the prognosis of patients with sepsis/septic shock. Logistic regression was used to analyze the risk factors of 28-day death.
RESULTS: Eleven patients with sepsis, 25 patients with septic shock and 30 healthy individuals were enrolled. Among the patients with sepsis/septic shock, 15 died in 28-day and 21 survived. The serum levels of TNF-α, IL-10, HMGB1, vWF, sTM and VEGFR-2 in patients with sepsis were significantly higher than those in the healthy control group. The levels of TNF-α, IL-10, HMGB1, vWF, sTM in septic shock group were higher than those in the sepsis group, while the Ang-2 level decreased significantly. The serum levels of TNF-α, IL-10, HMGB1, vWF and sTM in the death group were higher than those in the survival group, while Ang-2 was lower than the survival group. Spearman correlation analysis showed that HMGB1, TNF-α, sTM, IL-10, vWF were positively correlated with APACHE II score when patients with sepsis/septic shock were enrolled (r values were 0.652, 0.666, 0.445, 0.430 and 0.355, respectively, all P < 0.05), and HMGB1, TNF-α also positively correlated with SOFA score (r values were 0.433, 0.479, both P < 0.05). Ang-2 was negatively correlated with APACHE II and SOFA scores (r values were -0.519, -0.440, both P < 0.05). ROC curve analysis showed that the predictive value of HMGB1, vWF, IL-10, sTM for 28-day death in patients with sepsis/septic shock were higher than the APACHE II score [the area under ROC curve (AUC) and 95% confidence interval (95%CI): 0.946 (0.870-1.000), 0.902 (0.790-1.000), 0.877 (0.745-1.000), 0.868 (0.734-1.000) vs. 0.846 (0.700-0.991)]. Logistic regression analysis showed that APACHE II score, vWF, sTM, and IL-10 were independent risk factors for 28-day death in patients with sepsis/septic shock (β values were 4.731, 0.407, -7.058, -0.887, all P < 0.05).
CONCLUSIONS: HMGB1, vWF, IL-10, sTM and other cytokines all can be used to evaluate the severity and prognosis of sepsis patients.
参考来源
- Chen Y, Huang X, Kong G, et al. [Significance of high mobility group box 1, von Willebrand factor and other cytokines in the evaluation of severity and prognosis of sepsis patients]. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2020. PMID: 32912405. doi:10.3760/cma.j.cn121430-20200428-00346
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。